Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Authors' reply.

Truitt KE, Anderson RP.

Aliment Pharmacol Ther. 2019 Oct;50(8):956-957. doi: 10.1111/apt.15494. No abstract available.

PMID:
31591779
2.

Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease.

Goel G, Daveson AJM, Hooi CE, Tye-Din JA, Wang S, Szymczak E, Williams LJ, Dzuris JL, Neff KM, Truitt KE, Anderson RP.

Clin Exp Immunol. 2019 Sep 10. doi: 10.1111/cei.13369. [Epub ahead of print]

PMID:
31505020
3.

Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.

Tye-Din JA, Daveson AJM, Ee HC, Goel G, MacDougall J, Acaster S, Goldstein KE, Dzuris JL, Neff KM, Truitt KE, Anderson RP.

Aliment Pharmacol Ther. 2019 Oct;50(8):901-910. doi: 10.1111/apt.15477. Epub 2019 Sep 4.

PMID:
31483515
4.

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.

Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, Sarna VK, Wang S, Goldstein KE, Dzuris JL, Williams LJ, Xavier RJ, Lundin KEA, Jabri B, Sollid LM, Anderson RP.

Sci Adv. 2019 Aug 7;5(8):eaaw7756. doi: 10.1126/sciadv.aaw7756. eCollection 2019 Aug.

5.

Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.

Truitt KE, Daveson AJM, Ee HC, Goel G, MacDougall J, Neff K, Anderson RP.

Aliment Pharmacol Ther. 2019 Sep;50(5):547-555. doi: 10.1111/apt.15435. Epub 2019 Aug 13.

PMID:
31407810
6.

Standards for distribution models in biodiversity assessments.

Araújo MB, Anderson RP, Márcia Barbosa A, Beale CM, Dormann CF, Early R, Garcia RA, Guisan A, Maiorano L, Naimi B, O'Hara RB, Zimmermann NE, Rahbek C.

Sci Adv. 2019 Jan 16;5(1):eaat4858. doi: 10.1126/sciadv.aat4858. eCollection 2019 Jan. Review.

7.

Lung injury from inhaling butane hash oil mimics pneumonia.

Anderson RP, Zechar K.

Respir Med Case Rep. 2019 Jan 4;26:171-173. doi: 10.1016/j.rmcr.2019.01.002. eCollection 2019.

9.

Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac disease.

Yohannes DA, Freitag TL, de Kauwe A, Kaukinen K, Kurppa K, Wacklin P, Mäki M, Arstila TP, Anderson RP, Greco D, Saavalainen P.

Sci Rep. 2017 Dec 21;7(1):17977. doi: 10.1038/s41598-017-18137-9.

10.

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Daveson AJM, Ee HC, Andrews JM, King T, Goldstein KE, Dzuris JL, MacDougall JA, Williams LJ, Treohan A, Cooreman MP, Anderson RP.

EBioMedicine. 2017 Dec;26:78-90. doi: 10.1016/j.ebiom.2017.11.018. Epub 2017 Nov 22.

11.

Toward ecologically realistic predictions of species distributions: A cross-time example from tropical montane cloud forests.

Guevara L, Gerstner BE, Kass JM, Anderson RP.

Glob Chang Biol. 2018 Apr;24(4):1511-1522. doi: 10.1111/gcb.13992. Epub 2017 Dec 12.

PMID:
29156083
12.

Dual Recombinase-Mediated Cassette Exchange by Tyrosine Site-Specific Recombinases.

Voziyanova E, Anderson RP, Voziyanov Y.

Methods Mol Biol. 2017;1642:53-67. doi: 10.1007/978-1-4939-7169-5_4.

PMID:
28815493
13.

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Goel G, King T, Daveson AJ, Andrews JM, Krishnarajah J, Krause R, Brown GJE, Fogel R, Barish CF, Epstein R, Kinney TP, Miner PB Jr, Tye-Din JA, Girardin A, Taavela J, Popp A, Sidney J, Mäki M, Goldstein KE, Griffin PH, Wang S, Dzuris JL, Williams LJ, Sette A, Xavier RJ, Sollid LM, Jabri B, Anderson RP.

Lancet Gastroenterol Hepatol. 2017 Jul;2(7):479-493. doi: 10.1016/S2468-1253(17)30110-3. Epub 2017 May 11.

14.

Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease.

Cook L, Munier CML, Seddiki N, van Bockel D, Ontiveros N, Hardy MY, Gillies JK, Levings MK, Reid HH, Petersen J, Rossjohn J, Anderson RP, Zaunders JJ, Tye-Din JA, Kelleher AD.

J Allergy Clin Immunol. 2017 Dec;140(6):1592-1603.e8. doi: 10.1016/j.jaci.2017.02.015. Epub 2017 Mar 8.

15.

The 'Tully monster' is a vertebrate.

McCoy VE, Saupe EE, Lamsdell JC, Tarhan LG, McMahon S, Lidgard S, Mayer P, Whalen CD, Soriano C, Finney L, Vogt S, Clark EG, Anderson RP, Petermann H, Locatelli ER, Briggs DE.

Nature. 2016 Apr 28;532(7600):496-9. doi: 10.1038/nature16992. Epub 2016 Mar 16.

PMID:
26982721
16.

Are we overestimating the niche? Removing marginal localities helps ecological niche models detect environmental barriers.

Soley-Guardia M, Gutiérrez EE, Thomas DM, Ochoa-G J, Aguilera M, Anderson RP.

Ecol Evol. 2016 Jan 28;6(5):1267-79. doi: 10.1002/ece3.1900. eCollection 2016 Mar.

17.

Reply.

Hardy MY, Anderson RP, Tye-Din JA.

Gastroenterology. 2016 Mar;150(3):779-80. doi: 10.1053/j.gastro.2016.01.027. Epub 2016 Jan 27. No abstract available.

PMID:
26826377
18.

Understanding Policy Diffusion in the U.S.: An Information-Theoretical Approach to Unveil Connectivity Structures in Slowly Evolving Complex Systems.

Anderson RP, Jimenez G, Bae JY, Silver D, Macinko J, Porfiri M.

SIAM J Appl Dyn Syst. 2016;15(3):1384-1409. doi: 10.1137/15M1041584. Epub 2016 Jul 27.

19.

Efficient Genome Manipulation by Variants of Site-Specific Recombinases R and TD.

Voziyanova E, Anderson RP, Shah R, Li F, Voziyanov Y.

J Mol Biol. 2016 Feb 27;428(5 Pt B):990-1003. doi: 10.1016/j.jmb.2015.11.002. Epub 2015 Nov 7.

20.

All the better to see you with: eyes and claws reveal the evolution of divergent ecological roles in giant pterygotid eurypterids.

McCoy VE, Lamsdell JC, Poschmann M, Anderson RP, Briggs DE.

Biol Lett. 2015 Aug;11(8). pii: 20150564. doi: 10.1098/rsbl.2015.0564.

21.

Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease.

Hardy MY, Girardin A, Pizzey C, Cameron DJ, Watson KA, Picascia S, Auricchio R, Greco L, Gianfrani C, La Gruta NL, Anderson RP, Tye-Din JA.

Gastroenterology. 2015 Nov;149(6):1541-1552.e2. doi: 10.1053/j.gastro.2015.07.013. Epub 2015 Jul 29.

PMID:
26226573
22.

Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides.

Hardy MY, Tye-Din JA, Stewart JA, Schmitz F, Dudek NL, Hanchapola I, Purcell AW, Anderson RP.

J Autoimmun. 2015 Jan;56:56-65. doi: 10.1016/j.jaut.2014.10.003. Epub 2014 Nov 1.

PMID:
25457306
23.

A jump persistent turning walker to model zebrafish locomotion.

Mwaffo V, Anderson RP, Butail S, Porfiri M.

J R Soc Interface. 2015 Jan 6;12(102):20140884. doi: 10.1098/rsif.2014.0884.

24.

A framework for using niche models to estimate impacts of climate change on species distributions.

Anderson RP.

Ann N Y Acad Sci. 2013 Sep;1297:8-28. doi: 10.1111/nyas.12264.

PMID:
25098379
25.

What big eyes you have: the ecological role of giant pterygotid eurypterids.

Anderson RP, McCoy VE, McNamara ME, Briggs DE.

Biol Lett. 2014 Jul;10(7). pii: 20140412. doi: 10.1098/rsbl.2014.0412.

26.

T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease.

Petersen J, Montserrat V, Mujico JR, Loh KL, Beringer DX, van Lummel M, Thompson A, Mearin ML, Schweizer J, Kooy-Winkelaar Y, van Bergen J, Drijfhout JW, Kan WT, La Gruta NL, Anderson RP, Reid HH, Koning F, Rossjohn J.

Nat Struct Mol Biol. 2014 May;21(5):480-8. doi: 10.1038/nsmb.2817. Epub 2014 Apr 28.

PMID:
24777060
27.

Coeliac disease patients do not produce antibodies to a common cerebellar epitope.

Tarlac V, Kelly L, Anderson RP, Bye N, Storey E.

Cerebellum Ataxias. 2014 Dec 14;1:18. doi: 10.1186/s40673-014-0018-3. eCollection 2014.

29.

A scripted control system for autonomous hardware-timed experiments.

Starkey PT, Billington CJ, Johnstone SP, Jasperse M, Helmerson K, Turner LD, Anderson RP.

Rev Sci Instrum. 2013 Aug;84(8):085111. doi: 10.1063/1.4817213.

PMID:
24007111
30.

A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways.

Anderson RP, Henry MJ, Taylor R, Duncan EL, Danoy P, Costa MJ, Addison K, Tye-Din JA, Kotowicz MA, Knight RE, Pollock W, Nicholson GC, Toh BH, Brown MA, Pasco JA.

BMC Med. 2013 Aug 28;11:188. doi: 10.1186/1741-7015-11-188.

31.

Efficient Flp-Int HK022 dual RMCE in mammalian cells.

Voziyanova E, Malchin N, Anderson RP, Yagil E, Kolot M, Voziyanov Y.

Nucleic Acids Res. 2013 Jul;41(12):e125. doi: 10.1093/nar/gkt341. Epub 2013 Apr 29.

32.

A versatile high resolution objective for imaging quantum gases.

Bennie LM, Starkey PT, Jasperse M, Billington CJ, Anderson RP, Turner LD.

Opt Express. 2013 Apr 8;21(7):9011-6. doi: 10.1364/OE.21.009011.

PMID:
23571991
33.

Vaccine against autoimmune disease: antigen-specific immunotherapy.

Anderson RP, Jabri B.

Curr Opin Immunol. 2013 Jun;25(3):410-7. doi: 10.1016/j.coi.2013.02.004. Epub 2013 Mar 13. Review.

34.

PHI: a powerful new program for the analysis of anisotropic monomeric and exchange-coupled polynuclear d- and f-block complexes.

Chilton NF, Anderson RP, Turner LD, Soncini A, Murray KS.

J Comput Chem. 2013 May 15;34(13):1164-75. doi: 10.1002/jcc.23234. Epub 2013 Feb 5.

PMID:
23386394
35.

HLA-DR3-DQ2 mice do not develop ataxia in the presence of high titre anti-gliadin antibodies.

Tarlac V, Kelly L, Nag N, Allen-Graham J, Anderson RP, Storey E.

Cerebellum. 2013 Jun;12(3):370-6. doi: 10.1007/s12311-012-0425-z.

PMID:
23086706
36.

Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease.

Broughton SE, Petersen J, Theodossis A, Scally SW, Loh KL, Thompson A, van Bergen J, Kooy-Winkelaar Y, Henderson KN, Beddoe T, Tye-Din JA, Mannering SI, Purcell AW, McCluskey J, Anderson RP, Koning F, Reid HH, Rossjohn J.

Immunity. 2012 Oct 19;37(4):611-21. doi: 10.1016/j.immuni.2012.07.013. Epub 2012 Oct 11.

37.

World perspective on celiac disease.

Catassi C, Anderson RP, Hill ID, Koletzko S, Lionetti E, Mouane N, Schumann M, Yachha SK.

J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):494-9. doi: 10.1097/MPG.0b013e318272adf4. Review. No abstract available.

PMID:
22983371
38.

Partial-transfer absorption imaging: a versatile technique for optimal imaging of ultracold gases.

Ramanathan A, Muniz SR, Wright KC, Anderson RP, Phillips WD, Helmerson K, Campbell GK.

Rev Sci Instrum. 2012 Aug;83(8):083119.

PMID:
22938286
39.

Small bowel endoscopy and coeliac disease.

Daveson AJ, Anderson RP.

Best Pract Res Clin Gastroenterol. 2012 Jun;26(3):315-23. doi: 10.1016/j.bpg.2012.03.004. Review.

PMID:
22704573
40.

Harnessing the world's biodiversity data: promise and peril in ecological niche modeling of species distributions.

Anderson RP.

Ann N Y Acad Sci. 2012 Jul;1260:66-80. doi: 10.1111/j.1749-6632.2011.06440.x. Epub 2012 Feb 21.

PMID:
22352858
41.

Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.

Sollid LM, Qiao SW, Anderson RP, Gianfrani C, Koning F.

Immunogenetics. 2012 Jun;64(6):455-60. doi: 10.1007/s00251-012-0599-z. Epub 2012 Feb 10. Review.

42.

Flp and Cre expressed from Flp-2A-Cre and Flp-IRES-Cre transcription units mediate the highest level of dual recombinase-mediated cassette exchange.

Anderson RP, Voziyanova E, Voziyanov Y.

Nucleic Acids Res. 2012 Apr;40(8):e62. doi: 10.1093/nar/gks027. Epub 2012 Jan 23.

43.

Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.

McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, Ruyssers NE, Speare R, McCarthy JS, Engwerda CR, Croese J, Loukas A.

PLoS One. 2011;6(9):e24092. doi: 10.1371/journal.pone.0024092. Epub 2011 Sep 16.

44.

Coeliac disease is on the rise.

Anderson RP.

Med J Aust. 2011 Mar 21;194(6):278-9.

PMID:
21426277
45.

Dissecting the T-cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity.

Tanner GJ, Howitt CA, Forrester RI, Campbell PM, Tye-Din JA, Anderson RP.

Aliment Pharmacol Ther. 2010 Nov;32(9):1184-91. doi: 10.1111/j.1365-2036.2010.04452.x. Epub 2010 Sep 15.

46.

Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.

Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AV, McCluskey J, Rossjohn J, Anderson RP.

Sci Transl Med. 2010 Jul 21;2(41):41ra51. doi: 10.1126/scitranslmed.3001012.

47.

Non-axial bone fracture but not depression as a risk factor for coeliac disease.

Tan VP, Ching SL, Anderson RP, Gibson PR.

Intern Med J. 2010 Mar;40(3):225-7. doi: 10.1111/j.1445-5994.2009.02153.x.

PMID:
20446968
48.
49.

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.

Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, Botwick W, Shreeniwas R.

Clin Immunol. 2010 Mar;134(3):289-95. doi: 10.1016/j.clim.2009.11.001. Epub 2009 Nov 25.

PMID:
19942485
50.

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.

Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP; Society of Thoracic Surgeons Quality Measurement Task Force.

Ann Thorac Surg. 2009 Jul;88(1 Suppl):S43-62. doi: 10.1016/j.athoracsur.2009.05.055.

PMID:
19559824

Supplemental Content

Loading ...
Support Center